Leslie Meltzer
Hoofd Techniek/Wetenschap/O&O bij ORCHARD THERAPEUTICS PLC
Actieve functies van Leslie Meltzer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ORCHARD THERAPEUTICS PLC | Hoofd Techniek/Wetenschap/O&O | 01-06-2018 | - |
Loopbaan van Leslie Meltzer
Eerdere bekende functies van Leslie Meltzer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
KERYX BIOPHARMACEUTICALS | Hoofd Techniek/Wetenschap/O&O | 01-08-2016 | 01-06-2018 |
Opleiding van Leslie Meltzer
Stanford University School of Medicine | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 3 |
Verenigd Koninkrijk | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Orchard Therapeutics Plc
Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Leslie Meltzer
- Ervaring